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Abstract: This work reviews the literature of chiral capillary electrokinetic chromatography from
January 2016 to March 2021. This is done to explore the state-of-the-art approach and recent develop-
ments carried out in this field. The separation principle of the technique is described and supported
with simple graphical illustrations, showing migration under normal and reversed polarity modes
of the separation voltage. The most relevant applications of the technique for enantioseparation of
drugs and other enantiomeric molecules in different fields using chiral selectors in single, dual, or
multiple systems are highlighted. Measures to improve the detection sensitivity of chiral capillary
electrokinetic chromatography with UV detector are discussed, and the alternative aspects are ex-
plored, besides special emphases to hyphenation compatibility to mass spectrometry. Partial filling
and counter migration techniques are described. Indirect identification of the separated enantiomers
and the determination of enantiomeric migration order are mentioned. The application of Quality by
Design principles to facilitate method development, optimization, and validation is presented. The
elucidation and explanation of chiral recognition in molecular bases are discussed with special focus
on the role of molecular modeling.
Keywords: chiral capillary electrokinetic chromatography; enantioseparation; chiral selector; capil-
lary electrophoresis; Quality by Design; enantiomers; capillary electrophoresis-mass spectrometry;
enantiomeric impurity; molecular modeling; chiral recognition
1. Introduction
Chirality plays a crucial role in life with a multidisciplinary interest—including, but
not limited to, chemistry, biochemistry, food chemistry, agrochemistry, drug discovery,
pharmacology, engineering, physics, and material science. Stemming from the chirality of
natural amino acids, stereospecificity is a characteristic of many physiological reactions
and pharmacological processes for all living systems [1–4].
Methods for enantioseparation, particularly on an analytical scale, are still gaining
attraction, due to the continuous need for chiral separation and determination in different
research and industrial fields. Enantiomers that have identical physical and chemical prop-
erties, might produce different pharmacological responses. Some counter enantiomers are
recognized as being pharmacologically same active, less active, different active, inactive, an-
tagonistic, or even toxic compared to their active enantiomeric pair. Distomer is considered
the less potent, while the eutomer is more powerful for a particular action [5–11].
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Even when only considering the presence of inactive counter enantiomer of a drug
in racemate, it constitutes an additional load on the body without benefit. Therefore, the
number of drugs that are produced as enantiomers continually increases the expense of
racemate drugs. Thus, there is usually a need for enantioselective methods to separate and
quantitate enantiomers, but also to determine enantiomeric impurities with high sensitivity,
which must be in accordance with the International Conference on Harmonization (ICH)
regulations to quantify enantiomeric impurity of 0.1% relative to the main enantiomer. This
has been established in the guidelines of ICH and the other regulatory authorities, such as
the Food and Drug Administration (FDA) and European Medical Agency (EMA), for the
validation of analytical methods [12].
Possible racemization of a single enantiomeric drug might occur during synthesis,
storage, or in vivo metabolism. Possible in vivo inversion of a single enantiomeric drug (eu-
tomer) to produce the unwanted enantiomer (distomer) in the biological system should be
considered early during drug development. In vivo metabolism studies in rats are usually
conducted using a proper enantioseparation method [13]. Furthermore, the determination
of drug enantiomer, or its metabolite from biological body fluid and tissue samples, is
highly valuable to study for its stereoselective pharmacokinetic and pharmacodynamic
properties, to understand their enantioselective drug action in addition to stereoselective
drug interaction and toxicity [6,14].
Enantioseparation methods are also important in food analysis of protein amino acids,
organic acids, and sugars. For instance, it is necessary to check the absence of D-amino
acids in food proteins, which might be formed due to racemization of natural L-amino
acids during food production technology (e.g., treatment by alkaline conditions or heat).
The presence of D-amino acids will decrease the susceptibility of the proteins to proteolytic
enzymes [15,16].
Enantiomeric analytical methods are also required for agrochemical analysis of chiral
pesticides and insecticides [17]. Environmental analysis of contaminated water (e.g., phar-
maceutical wastewater), soil, and food by residues of chiral drug and/or their metabolites
and chiral pesticides is an important field. Enantioselective separation is mandatory to
explore the potential of these substances to exhibit stereoselective toxicity or degradation
and its consequences on animals and humans [18,19]. Enantioseparation is also important
in doping and forensic science.
Capillary electrophoresis (CE) and capillary electrochromatography (CEC) play more
competitive and complementary roles to liquid chromatography (LC) than the other tech-
niques for chiral separation, such as gas chromatography (GC) and supercritical fluid
chromatography (SFC), and to less extent thin layer chromatography (TLC) [6,20–25].
Microchips also contribute to the field of enantiomeric separation and detection with
successful applications [26].
Compared to LC, the application of CE for chiral analysis involves lower sample
and reagent consumption, making it a green alternative enantioseparation technique. CE
techniques are also known to offer higher separation efficiency and resolution and mostly
lower analysis time than HPLC. However, LC remains superior with regard to UV detection
sensitivity and also mostly with regard to the repeatability of migration time and peak area.
Moreover, the chiral separation principle in CE is different from that in HPLC, as described
below. Therefore, CE is a good complementary technique to HPLC for chiral separation. It
is also worth noting that most successful chiral selectors in HPLC can be transferred to CE
except for aqueous buffer insoluble ones [27].
Among other CE modes, electrokinetic chromatography (EKC) is a widely used
CE mode for enantioseparation [6,28,29]. EKC modes include micellar electrokinetic
chromatography (MEKC), in which a micelle is used with or without chiral selector (CS)
as a pesudostationary phase (PSP), and microemulsion electrokinetic chromatography
(MEEKC), in which a microemulsion is used as carrier electrolyte. The present review
draws attention to nonmicellar chiral capillary electrokinetic chromatography (CEKC) as
a well-established technique for enantioseparation. The use of chiral MEKC is limited
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because uncharged enantiomeric compounds can also be separated by nonmicellar CEKC
with the charged chiral selector. MEKC and MEEKC are out of the scope of this review and
are described elsewhere [30–36].
This review gives an overview of the development and application of CEKC from
January 2016 to March 2021. Methodological and application advances, for the use of the
technique in the enantiomeric separation and enantiomeric impurity determination, are
discussed, and new chiral selectors are reported. In addition, the successful use of Quality
by Design is explored, and the application to elucidate the mechanism of enantiomeric
separation and the enantiomer migration order (EMO) is critically reviewed with special
highlights on challenges, solutions, and future aspects.
2. Chiral Capillary Electrokinetic Chromatography Principle and Selectors
2.1. Principle of CEKC
CEKC is a CE mode in which a CS is added directly to the background electrolyte
(BGE). The separation of molecules will then result from the dynamic equilibrium with the
CS inside the capillary and their different electrophoretic mobilities, if present, in a charged
form in the BGE [37,38].
The added CS to the BGE will form noncovalent transient diastereomeric complexes
with each of the two enantiomers of mostly the same drug with different complexation
constants, and thus, different complex stability. In addition to the nonstereospecific binding
forces, each enantiomer will form additional stereospecific binding with the chiral selector,
mostly hydrogen bonding, but also forces like hydrophobic, electrostatic, van der Walls,
and steric factors. In addition to possible inclusion forces, if cavity (or more) is/are
available within the structure of the CS, then part of the enantiomer can pass inside. The
two enantiomers will mostly have different affinity to the CS, i.e., the enantioseparation
can be reached by different intermolecular forces and thermodynamic selectivity in the
recognition mechanism [39–41].
It is proven, however, that it is possible in CE, and not in HPLC, that the enantiosepa-
ration selectivity can exceed the thermodynamic selectivity of the recognition. Therefore,
CE can separate an enantiomeric pair of a compound even if the binding constants of its
individual enantiomers with the CS are identical. That is to say, both or either a binding
constant difference or analyte difference is/are required to achieve enantioseparation in
CEKC [27,42].
Therefore, each enantiomer will migrate with a different speed (electrophoretic mi-
gration) because of the different interactions with the chiral selector, and thus, the two
enantiomers will separate from one another. High flexibility is offered in choosing one (or
more) of a variety of CS available for enantioseparation and simply adding it/them to the
BGE in combination or not. This also offers the ability to easily adjusting the concentration
of the CS to achieve the best equilibrium and to modify the electroosmotic flow (EOF)
velocity through an effect on viscosity for best enantioseparation [43,44].
The CS can easily and cost-effectively be replaced by another in CEKC to identify the
one with the best separation power for the intended enantiomeric molecules or to invert
the migration order of the enantiomer peak pair. The concentration of the CS can also be
modified for best selectivity [21,28].
CEKC can be conducted under normal or reversed polarity modes of the separation
voltage. Enantiomers will migrate in a direction depending on its apparent mobility (µapp),
which is the sum of the electrophoretic mobility (µe) and the EOF mobility (µEOF), but
also influenced by the µapp of the CS to which it will complex. The normal polarity of the
separation voltage (Figure 1) indicates having the anode (+) at the inlet and the cathode
(−) at the outlet. Under the normal polarity mode of the separation voltage, the EOF is
towards the cathode (detector/outlet). The normal polarity mode of the separation voltage
is the standard mode in CE. In contrast, the separation can be conducted under a reversed
polarity mode of the separation voltage. The reversed polarity mode of the separation
voltage indicates having the cathode at the inlet and the anode at the outlet. Under reversed
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polarity of the separation voltage, the direction of the EOF will be mostly away from the
detector, except if a zero-flow capillary or a low pH BGE is used. Negatively charged
enantiomers with electrophoretic mobility greater than the EOF will pass the detector.
Negatively charged cyclodextrins (CDs) have strong electrophoretic mobility toward the
positive electrode (anode). Basic drugs are positively charged under low pH buffer and
are more likely to interact with negatively charged CD, and then the CD drug complex
will be attracted toward the anode at the outlet and pass the detection window (Figure 2).
Therefore, the negatively charged CDs will act as a carrier of enantiomers by their self-
mobility toward the anode at the outlet [36,45–48].
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(µapp) of the enantiomeric pair and the mobility of the EOF (µEOF), respectively. The blue arrows show the difference in the
speed of the migration of enantiomers upon interaction with the CS. µapp of the CS would be according to its charge.
2.2. Types of Chiral Selectors in CEKC
Over the past years, many substances have been successfully used or unsuccessfully
tried (e.g., without achieving the required resolution) as chiral BGE additives in nonmi-
cellar CEKC to separate enantiomeric pairs. In principle, any substance with potential
enantiomeric separation power, good stability in the BGE, and compatibility with the
detection mode can be tried. Recently, new substances are showing good ability to separate
enantiomers [49,50]. Additional special considerations should be taken, for example, when
using EKC-mass spectrometry (MS), as described in Section 3.1.
In a published work from September 2020 about recent advances of novel chiral
separation systems in CE, Qi [51] provided a circular statistical graphic (circle chart) divided
int slices to illustrate the numerical proportion of the application of CSs in enantiomeric
separation by CE, as s own in Figure 3.
A similar chart with a special focus on CSs in CEKC during 2017–2018 has before
been published by Yu and Quirino [28]. Both authors show that derivatized CDs as a
single selector are the most commonly used CSs and are responsible for about 50% of chiral
separation methods.
Up-to-date derivatized CDs, which are formed through chemical substitutions with a
stronger recognition ability and/or better solubility, are still pioneering the field of CSs in
CEKC to separate enantiomers in either pharmaceutical formulations, biological samples,
or other fields [52].
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Figure 3. The proportion of application of the various chiral selectors in CE in 2015–2019 (incomplete
statistics). Reprinted with permission from reference [51].
Uncharged derivatized CDs include substances as hydroxypropyl-α-CD, hydroxypropyl-
β-CD, and hydroxypropyl-γ-CD. Negatively charged derivatized include high sulfated-
α-CD, high sulfated-β-CD, high sulfated-γ-CD, s lfobutyl-ether-β-CD, carboxymethyl-
β-CD, ph sphated-α-CD, phosphated-β-CD, phosphated-γ-CD, and succinylated-β-CD.
Positively charged erivatized CDs as a quaternary ammonium CD also showed successful
applications. Among others, hydroxypropyl derivatized CDs are claimed to have the best
enantioseparation power for a wider variety of chiral compounds [6,52–55].
Negatively charged CDs (anionic CDs) are also especially important and widely
applied for the enantioseparation of positively charged cationic compounds (basic chiral
compounds) and neutral chiral compounds [56].
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The single isomer CDs are preferred for chiral separation to obtain reproducible results,
but also to study aspects of the selector-analyte interactions and to better understand the
experimental design of chiral CE separations [53].
The CDs have been applied mostly as a single chiral selector, but also sometimes in
a dual or multiple chiral system, as described below. Tuning of enantio-discrimination
can be achieved by substitution of the single CD molecule, but also fine-tuning is possible
by modifying the other separation conditions [53]. Cucinotta et al. [57] synthesized and
characterized a new capped derivative of β-CD. The synthesized new lysin-bridged hemi-
spherodextrin was characterized by electrospray ionization mass spectrometry (ESI-MS)
and Nuclear magnetic resonance (NMR) spectroscopy. Circular dichroism and electron
spin resonance spectroscopy were used to test its inclusion ability and its metal coordi-
nation ability, respectively. The new selector has been used to separate enantiomers with
improved ability toward anionic and cationic guests compared to the single free CD. Re-
cently, Salido et al. [58] reported the effect of eutectic solvents as choline chloride-ethylene
glycol, choline chloride-urea, choline chloride-D-glucose, and choline chloride-D-sorbitol
as additives in CD mediated CEKC to improve the enantioseparation of lacosamide enan-
tiomers. The addition of choline chloride-D-sorbitol to the separation media containing
succinyl-β-CD has been found to increase the resolution value from 1.5 to 2.8.
Room temperature ionic liquids (ILs) are the second most commonly used CSs in
CEKC after CDs. ILs are responsible for about 17% of chiral separation. Chiral ILs (CILs)
are organic salts that consist of organic cation and an organic or inorganic anion. Either
the cation or the anion must be chiral to consider as CILs [28,59]. Recently, Nie et al. [60]
reviewed and categorized ILs for enantioseparation and explored their resolution mecha-
nism. Amino acid-based ILs have been proposed for potential use as sole CSs in CEKC [61].
Zhang et al. [62] reported the potential use of novel mono- and di-tetraalkylammonium
L-tartrate ILs with different alkane chain lengths as sole CSs in CE. Successful enantiosepa-
ration of five model chiral analytes has been obtained with a high proportion of methanol.
In many cases, ILs could not show enough enantiomeric discrimination power when used
as sole CSs, and thus, have been usually used in combination with other CSs, mostly CDs,
and particularly the derivatized ones. They act in synergism together to achieve better
enantioseparation. It is suggested that the mechanism of separation is then based on the
competition of the chiral IL and the enantiomer for inclusion into CD [63–67]. Wahl and
Holzgrabe prepared and used ILs combining tetrabutylammonium cations with chiral
amino acid-based anions (tetrabutylammonium l-argininate) together with β-CD for the
enantioseparation of ephedrine, pseudoephedrine, and methylephedrine isomers [68].
Polysaccharides, either the homo-polysaccharides as maltodextrin or the glycosamino-
glycan as chondroitin sulfate and heparin, are contributing to about 5% of chiral separation
and are much behind CDs in their enantiomeric discrimination power [69–71]. Sun et al. [72]
described a CEKC approach using ethanediamine-bonded poly (glycidyl methacrylate)
microspheres as CSs for enantioseparation with chondroitin sulfate E. Better enantiosep-
aration results were obtained using the microsphere for separating basic model chiral
compounds compared with using the single system of chondroitin sulfate E.
Macrocyclic antibiotics have molecular masses range between 600 and 2200. Their
enantioseparation power is because they have multiple stereogenic centers. Most are
accessible in charged forms, and thus, suit CEKC of uncharged enantiomeric drugs [73].
Examples include eremomycin, rifamycin B, vancomycin, thiostrepton, ristocetin A, fra-
diomycin, teicoplanin, azithromycin, erythromycin, and clarithromycin. Most of them have
several chiral centers with or without cavities (e.g., teicoplanin has 23 chiral centers and
4 cavities), ensuring good enantioseparation power [74]. Post run washing of the capillary
and the use of small volume samples have been recommended because of the strong ability
of the glycopeptide antibiotics to adsorb to the inner wall of the capillary [75,76].
Recently, Ren et al. [77] reported using the second-generation macrolide antibiotic
gamithromycin as a novel chiral selector for enantioseparation in CE. Gamithromycin
showed particular enantioseparation power for chiral primary amines.
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In another recently published research work, the steroid antibiotic fusidic acid has
been proposed as a novel chiral selector for enantioseparation in CE. The authors suggested
its special effective enantiodiscrimination power for chiral analytes containing rigid planar
structures. The authors expected the finding to open the door for investigating other
structurally similar steroids for possible enantioseparation power [78].
Chiral metal-ion complexes are small molecule chiral selectors for CEKC. Example
include Cu(II)-L-ornithine, Cu(II)-D-phenylalanine, Cu(II)-l-lysine, Cu(II)-D-quinic acid,
Zn(II)-l-arginine, Zn(II)-l-lysine, Co(II)-D-quinic acid and Ni(II)-d-quinic acid. They act
through the formation of diastereomeric ternary metal-ligand-analyte complexes. Meta
ligand complexes showed successful application for the enantioseparation of amino acids
and dansylated amino acids, and glycyl peptides [79,80].
Among proteins, human or bovine serum albumins are the most commonly used chi-
ral selectors in CEKC. A good washing protocol is required to minimize protein adsorption
to the inner surface of the fused silica capillary. Proteins are still playing a particularly
good role in investigating enantioselective protein interaction with enantiomeric drugs [81].
Ratih et al. [7] used human serum albumin as a chiral selector in 20 mM phosphate buffer
pH 7.4 for enantioseparation and simultaneous binding constant determination of amlodip-
ine and verapamil enantiomers. It is worth noting that microscale thermophoresis [82] also
is useful in the study of enantioselective affinity of chiral drugs toward therapeutic target
proteins [83].
Quintana et al. [84] synthesized carbosilane dendrimers functionalized with L-cysteine
and N-acetyl-L-cysteine on their surface and used them as CS to separate razoxane by
CEKC. Results showed partial resolution, but opens the door for more research in this
regard to explore the use of dendrimers as CSs in CEKC.
New selectors are continuously proposed to enhance enantioselectivity. Meanwhile,
modifications of existing selectors, for example, by derivatization, also takes place. How-
ever, random derivatization processes that cannot identically be repeated to produce the
same product are not recommended, even if a good separation is obtained, because no
result reproducibility can then be ensured.
Combination of two CSs in a dual chiral separation system or more in multiple chiral
separation systems have been reported to improve the enantioseparation [85,86]. A dual
chiral separation system is less complicated than the multiple ones, and is more commonly
used. This has been achieved mostly by adding the two CSs mixed together to the BGE
or sometimes by injecting them separately in two separated plugs without meeting each
other in the capillary. Many examples showed an enhanced separation efficiency through
the synergetic effect of dual CS systems of two mixed chiral selectors [87]. A dual CDs CS
system of sulfobutyl-ether-β-CD and native γ-CD resulted in a good enantioseparation
of lansoprazole and rabeprazole [88]. Nicolaou et al. [89] developed two dual CS systems
to separate the enantiomers of warfarin, coumachlor, nefopam, and fexofenadine using
either CD or cyclofructan with the CIL L-alanine tert butyl ester lactate. The addition
of the CIL to the BGE was found to improve the resolution. Six basic racemic drugs
(amlodipine, chlorphenamine, duloxetine, propranolol, nefopam, and citalopram) were
separated using a dual chiral selector system of chondroitin sulfate D and carboxymethyl-
β-CD [90]. Chen et al. [91] reported the synergetic action of the IL tetramethylammonium-
L-arginine and maltodextrin in enantioseparation of the five studied drugs, including
nefopam, duloxetine, ketoconazole, cetirizine, and citalopram. Better resolution values
were obtained compared to the single maltodextrin system. Salido-Fortuna et al. [92]
reported a CEKC method for the enantiomeric determination of econazole and sulconazole
in pharmaceutical formulation using a dual chiral system consisting of hydroxypropyl-β-
CD combined with ionic liquids. Best separation was obtained with hydroxypropyl-β-CD
combined with tetrabutylammonium-L-lysine. High enantiomeric resolution values for
econazole and for sulconazole have been achieved, as shown in Figure 4.
Some examples showed an enhanced separation efficiency through dual CS systems
in which the two chiral selectors are introduced to the capillary in two separated plugs.
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Chalavi et al. [93] developed an enantioseparation method based on the partial filling
technique with two chiral selector plugs. The first plug contains either hydroxypropyl-
α or β-CD and the second plug contains maltodextrin. The two adjacent chiral plugs
contain the same BGE. Each plug is supposed to separate the enantiomers independently.
This approach is aimed to prevent the possible unwanted interaction between the two
chiral selectors inside the capillary and is useful for chiral compounds that cannot be
separated using either one of the two intended chiral selectors or a mixture of them.
The method showed success in separating racemic drugs, including baclofen, carvedilol,
cetirizine, chlorpheniramine, citalopram, fluoxetine, hydroxyzine, propranolol, tramadol,
and trihexyphenidyl. No significant effect has been noted in selectivity factors (α) and
migration times, and no significant differences between the resolutions when the order of
the two chiral selector plugs in the capillary has been inverted. One should, however, note
that in other cases (e.g., CDs with ILs), the interaction between the two chiral selectors is
mostly advantageous and wanted to produce a synergetic effect.
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dard solution (40 mg/mL) and cream samples of econazole and sulconazole. CE conditions:
50 mM phosphate buffer pH 2.5 containing mixtures of (A) 5 mM hydroxypropyl-β-CD with
20 mM tetrabutylammonium-L-lysine at 25 ◦C; (B) 2 mM hydroxypropyl-β-CD with 25 mM
tetrabutylammonium-L-lysine at 15 ◦C. Other conditions: Uncoated fused silica capillary,
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Recently, La et al. [86] developed a CEKC method based on a multiple chiral separa-
tion system. The method has been used for separating dihydropyridone analog, a drug
candidate proposed in type 2 diabetes treatment, which is a neutral hydrophobic molecule
with multiple chiral centers. Its eight isomers have been successfully separated using a
triple CD system consisting of 15mM sulfobutyl-ether-β-CD plus 15mM γ-CD and 40 mM
hydroxypropyl-γ-CD in a 50 mM borate BGE at pH 10. Further relevant applications of
CEKC dating between January 2016 and March 2021, other than those described in the text
of this review, are summarized in Table 1.
Table 1. List of representative orks published between 2016 and March 2021 dealing with the application of CEKC in
enantiomeric separation and determination of enantiomeric compounds from different fields.
Analyte Matrix Separation Conditions Detection LOD/LOQ Ref.
Cathinone
derivatives Human hair
Preconcentration by solid phase extraction,
fused silica capillary of 50 µm i.d. and 80 cm
total length, separation voltage of 35 kV, BGE
of 80 mM isodium ph s hate at pH 2.5,
β-CD as CS
DAD at 200 nm 0.02 ng/mg0.2 ng/mg [94]
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chloroformate fused silica capillary of 50 µm
i.d. with a length of 70 cm to the detector and
80 cm of total length, separation voltage of
35 kV, BGE of 50 mM ammonium bicarbonate
at pH 8 containing 15% (v/v) isopropanol
and 10 mM β-CD, Sheath liquid interfacing
of propan-2-ol:water: 1 M ammonium
bicarbonate (50:50:1, v/v/v) at a flow rate of
3 L/min, and a nebulizer gas pressure of 2 psi
ESI-MS 0.9 µm- [95]
Tedizolid Pharmaceuticalformulation
Fused silica capillary of 45 cm (effective
length 35 cm) × 25 µm i.d., separation
voltage of 12 kV, BGE of 37.5 mM
heptakis-(2,3-diacetyl6-sulfo)-β-CD dissolved
in 50 mM formic buffer pH 4.0 with the
addition of acetonitrile (81.4:18.6, v/v)
DAD at 200 nm -- [96]
Radezolid Pharmaceuticalpreparation
Fused silica capillary of 45 total length and
35 cm effective length and 25 µm i.d.,
separation voltage −28 kV, BGE of 40 mM
heptakis(2,3-di-O-methyl-6-sulfo)-β-CD
dissolved in 50 mM phosphate buffer pH 2.5
DAD at 265 nm -- [97]
Methadone Exhaled breathcondensate
Fused silica capillary of 50 cm length, 41.5 cm
effective length, and 50 µm i.d., separation
voltage of 25 kV, BGE of 150 mM phosphoric
acid-tetraethylammonium at pH 2.5
containing 30% (v/v) methanol and 0.8%
(w/v) carboxymethyl-β-CD
DAD at 200 nm -0.15 µg/mL [98]
Colchicine Pharmaceuticalpreparation
Fused silica capillary 58.5 cm (50 cm effective
length) × 50 µm i.d., separation voltage of
20 kV, 50 mM or 25 mM borate buffer pH 9.0
using succinyl-γ-cyclodextrin or
sulfated-γ-CD
UV at 243 nm 0.3 mg/mL1 mg/mL [99]
Praziquantel Pharmaceuticalpreparation
Fused silica capillary of 50 µm i.d., 48.5 cm
total and 40 cm effective length, separation
voltage of 15 kV, BGE of 50 mM phosphate
buffer pH 2.0, supplied with 15 mM
sulfated-β-CD
DAD at 210 nm 0.75 µg/mL2.0 µg/mL [100]
Glycopyrrolate Rat plasma
Online preconcentration by cation-selective
exhaustive injection-sweeping, fused silica
capillary (40.2 cm × 75 µm), separation
voltage of −20 kV, BGE 30 mM phosphate
solution at pH 2.0 containing 20 mg/mL
sulfated-β-CD and 5% acetonitrile
DAD at 200 nm 2.0 ng/mL0.0625 µg/mL [101]
Brompheniramine Rat plasma
Online preconcentration by cation-selective
exhaustive injection and sweeping, fused
silica capillary of the total length of 50 cm
(effective length 40 cm) × 50 µm i.d.,
separation voltage of −20 kV, BGE in 50 mM
phosphate buffer pH 3.5, containing 10%
(v/v) acetonitrile and 30 mg/mL
sulfated-β-CD
UV at 210 nm -0.01 µg/mL [102]
Ivabradine Pharmaceuticalformulation
Fused silica capillary of 58.5 cm (50 cm to the
detector window) × 50 µm i.d., separation
voltage of −30 kV, BGE of 5 mM
tetrabutylammonium-aspartic acid in 50 mM
formate buffer pH 2.0 containing 4 mM
sulfated-γ-CD










Fused silica capillary of 48 cm total, and
40 cm effective length and 50 µm i.d.,
separation voltage of +20 kV, BGE for
lansoprazole: 25 mM phosphate buffer pH 7,
10 mM sulfobutyl-ether-β-CD/20mM γ-CD,
+20 kV voltage; BGE for rabeprazole: 25 mM
phosphate buffer pH 7, 15 mM
sulfobutyl-ether-β-CD/30 mM γ-CD
UV at 210 nm 2 and 2 µg/mL6 and 6 µg/mL [88]
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Analyte Matrix Separation Conditions Detection LOD/LOQ Ref.
Pheniramine Rat plasma
Online preconcentration by large volume
sample stacking and sweeping, fussed silica
capillary of a total length of 50 cm (effective
length 40 cm) × 50 µm i.d., separation
voltage of −20 kV, BGE of 30 mM phosphate
buffer at pH 3.0 with 30 mg/mL
sulfated-β-CD
UV at 262 nm -10 ng/mL [104]
Phenothiazines Urine sample
Preconcentration by solid phase extraction,
fused silica capillary of 75 µm i.d. and
365 µm o.d., separation voltage from 10 to
12 kV, BGE of 75 mM phosphate buffer pH 3.0
and 0.9% poly (diallyldimethylammonium
chloride), hydroxypropyl-γ-CD as a CS.











Fused silica capillary of 58.5 cm total length
and 50 cm length to the detector and 50 µm
i.d., separation voltage of 25 kV, BGE of
50 mM phosphate buffer pH 7.0, dual CD
(4 mM hydroxyl–β-CD and 16 mM
heptakis(2,3,6-tri-O-methyl)-β-CD.













chloroformate, fused silica capillary of
58.5 cm total length and 50 cm effective
length and 50 µm i.d., separation voltage
20 kV, BGE for homocysteine: 2 mM γ-CD
+5 mM L-Carnitine C1NTf2 in borate buffer
pH 9.0, BGE for Cysteine: 2 mM γ-CD +5 mM
L-CarnitineC1Lac in phosphate buffer pH 7.0
DAD at 210 nm -- [107]
Amlodipine Pharmaceuticalformulation
Fused silica capillary of 48 cm length (40 cm
effective length) ×50 µm i.d., separation
voltage of 25 kV, BGE of 25 mM phosphate
buffer pH 9.0, 15 mM carboxymethyl-β-CD















capillary fused silica with 75 µm i.d. and a
total length of 60 cm, separation voltage of
30 kV, BGE 137.5 mM borate buffer pH 10.25
and 12.5 mM β-CDs
LIF at
λex = 488 nm
and
λem = 522 nm
0.25 µmol/L [109]
Venlafaxine Pharmaceuticalpreparations
Fused silica capillary of 30 cm length
(effective length 22 cm) × 50 µm, separation
voltage of 25 kV, BGE of 25 mM phosphate
buffer pH 2.5, 10 mM carboxymethyl-β-CD

















Online preconcentration by large volume
sample stacking, fused silica capillary of
75 µm i.d. × 50 cm length, separation voltage
25 kV, BGE of 25 mM tetraborate pH 9.3
and α-CD












at 254 nm for
sorbic acid at
254 nm.
0.8 to 5 ng/mL






Fused silica capillary of a total length of
58.5 cm (50 cm effective length) and 50 µm
i.d., separation voltage of 30 kV, BGE of
25 mM (2-carboxyethyl)-β-CD in 100 mM
borate buffer pH 9.0
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3. Methodological and Instrumental Aspects
3.1. Detection Sensitivity
One main drawback of CE-UV is the lower concentration sensitivity compared to LC-
UV, which also applies in CEKC-UV, especially when intended to be used for enantiomeric
impurity quantitation from a pharmaceutical preparation or enantiomeric determination
from a biological sample. This stems from the lower injection volume in CE compared
to HPLC in addition to the short optical path-length of the capillary (capillaries are used
with diameters ranging between 25 to 100 µm, usually 50 µm). Therefore, a number of
in-capillary preconcentration techniques can be applied to increase the sensitivity of a
UV detector [113–115]. The use of different capillary forms with a longer path-length at
the detection window (e.g., bubble cell, bent cell, or multireflection capillaries) is also an
alternative to increase sensitivity.
It is important to note that two separated enantiomers may path the detection window
of a capillary connected to the detector with different speeds, the difference in mobility
residence in the detection window can create a difference in detection response between
the two enantiomers. This is particularly important to aware of when checking impurity
enantiomer percentage as %area/area.
In case of very low sensitivity detection or for non-UV-absorbing enantiomeric com-
pounds lacking the chromophoric group, using other detection techniques as, for ex-
ample, electrochemical or conductivity detection or mostly mass spectrometry is recom-
mended [116]. Derivatization can be performed to enhance detection. Wuethrich and
Quirino reviewed the four possible modes of derivatization for CE; precapillary, in-line,
in-capillary, and postcapillary derivatization [117]. The precapillary derivatization with
9-fluorenylmethyl chloroformate and subsequent UV-detection or MS detection is an option
for some compounds [118,119]. Laser-induced fluorescence (LIF) detection did not show
popularity in CEKC, due to the drawback of the molecular labeling used for enantiomeric
drug derivatization. Degradation products of the fluorophores can generate fluorescent
side products, which can interfere with the detection signal of the labeled low concentration
target enantiomer [120,121].
Alternatively, high sensitivity detection techniques as MS can be used. For enan-
tiomeric determination from biological samples with a complex matrix and usually a low
concentration of the target enantiomeric substances and/or its enantiomeric metabolites,
initial sample treatment is required via the use of a sample preconcentration technique.
The sample preconcentration is aimed to clean up the sample from the complex matrix
by extracting the target enantiomer, but also concentrating it to increase its detectability.
The most commonly used sample preconcentration technique is solid phase extraction
(SPE) [94,105].
SPE with different stationary phases as per target analyte, including, e.g., anion ex-
change or cation exchange cartridges, is the most commonly used sample preconcentration
technique. SPE cartridges for almost every kind of analytes are nowadays commercially
available. SPE process can simply be performed off-line, e.g., for research purpose, but
also on-line SPE is available for large scale analysis. Besides SPE, other preconcentra-
tion techniques as liquid-liquid extraction (LLE), liquid-liquid microextraction (LLME),
pressurized liquid extraction (PLE), dispersive liquid-liquid microextraction (DLLME),
electromembrane extraction (EME) have also been reported in enantiomeric separation
and quantitation by CE. Evaluation of each depends on extraction efficiency and recovery
percentage in addition to simplicity, speed, and cost-effectiveness [6]. It is worth noting that
subsequent on-line sample preconcentration techniques to focus the analyte on-capillary
before its detection as sweeping and stacking at the interface between the sample and BGE
zones to improve the detectability can be applied [114,115,122].
Hyphenation to MS offers higher sensitivity and selectivity and provides structural
information, which might be needed, especially when dealing with chiral metabolites.
Improved limits of detection (LODs) are usually obtained with CEKC-MS compared to
CEKC-UV. For CEKC-MS hyphenation, ammonium-based volatile buffer components
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should replace the classical nonvolatile buffer components of the BGE as phosphate and
borate buffers. The coupling of CEKC to MS is still not fully straightforward. The possibility
of the nonvolatile chiral (low molecular-weight) CSs to either induce ion suppression and
interfere with the MS signal in the m/z range of the enantiomeric analyte or induce source
contamination of the MS ion source and optics, thus decrease the sensitivity should be
considered. In this regard, a lower concentration of the selector or a slower EOF can
be considered to decrease the entry of the chiral selector to the ion source. It is worth
noting that a successful CEKC-MS has been reported using native β-CD with a moderately
tolerable ionization suppression allowing smooth coupling to MS [95,123].
Compared to chiral MEKC, the absence of surfactant in nonmicellar CEKC make it
more suitable for coupling with MS. However, in MEKC, a number of high molecular
mass polymeric chiral surfactants have been used as polymeric micelles to replace the
conventional surfactants forming micelles. They are claimed to remain intact and not
fragment in the gas phase of the mass spectrometer, thus offering better compatibility
of MEKC with MS by avoiding forming background ions from fragmented conventional
surfactants into surfactant monomers. Moreover, volatile PSPs have also been used in
chiral MEKC indirect mode based on derivatization of the analyte [30,124]. Likewise, stable
crown-ether complexes in CEKC are used without a problem when coupled with MS [125].
Two filling techniques are available to introduce the chiral selector into the BGE inside
the capillary with a selector-free detection window. The first is the partial filling technique
(PFT). PFT is an alternative CS filling technique to the complete filling technique (CFT).
CFT involves filling the capillary with CS, and then injecting the chiral compound, and
doing the CE run from a solution of chiral selector in the running buffer [29,126]. As an
alternative, the separation could be conducted by PFT, in which the CS is introduced into
the capillary from a solution of the CS in the buffer, and then the chiral compound is
injected. The run is subsequently conducted from a vial containing only the buffer without
the CS (Figure 5) [127,128].
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the enantiomeric compound (B), and conducting the run with a vial contain BGE (C). Pink, yellow 
and green arrows show the apparent mobility (µapp) of the enantiomeric pair, the CS, and the mo-
bility of the EOF (µEOF), respectively. The µapp of the CS is also in the direction of the cathode, but 
the migration speed of the CS is very slow compared to the migration speed of the two enantiomers; 
thus, the enantiomers can pass the CS plug rapidly. The blue arrows show the difference in the 
speed of the migration of enantiomers upon interaction with the CS. 
PFT reduces the consumption of the chiral selector. The technique works best if the 
enantiomers have apparent mobility higher than EOF mobility to be able to pass the chiral 
selector plug in the capillary. Otherwise, a low pH buffer is used to decrease EOF mobility, 
Figure 5. Representative schematic illustration of enantioseparation by CEKC applying PFT for
separating a basic ionized enantiomeric pair (R+ and S+) using CS in the BGE. Filling the CS (A),
injecting the enantiomeric compound (B), and conducting the run with a vial contain BGE (C). Pink,
yellow and green arrows show the apparent mobility (µapp) of the enantiomeric pair, the CS, and the
mobility of the EOF (µEOF), respectively. The µ pp of the CS is lso in the direction of the cathode, but
e migration speed of the CS is v ry slow compared to the mig ation speed of the two enan iomers;
thus, the enantiomers can pass the CS plug rapidly. The blue arrows show the difference in the speed
of the migration of enantiomers upon interaction with the CS.
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PFT reduces the consumption of the chiral selector. The technique works best if the
enantiomers have apparent mobility higher than EOF mobility to be able to pass the chiral
selector plug in the capillary. Otherwise, a low pH buffer is used to decrease EOF mobility,
or alternatively, a coated capillary is recommended [29]. The PFT is claimed to counter the
background absorbance when a UV detector is used and is more suitable to CEKC-MS to
avoid (or minimize) the entry of CS to the ion source [29,129].
Lee et al. [130] developed a CEKC-MS enantioseparation method for underivatized
free amino acids (AAs) using a PFT for the determination of D-AAs in vinegar. Crown
ether (18-crown-6)-2,3,11,12-tetracarboxylic acid (18C6H4) was used as chiral selector. The
method resulted in the simultaneous separation of seventeen AAs.
The second technique to minimize the entry of the selector to the ion source is the
use of the counter migration technique, in which the CS will have strong electrophoretic
mobility to the anode (stronger than the EOF) away from the cathodic end and the detector
(Figure 6). Therefore, the CS is supposed not to inter the ion source when the CEKC is
hyphenated with MS. Highly negatively charged derivatized CDs like sulfated-β-CDs can
experience this phenomenon [29,131].
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Figure 6. Representative schematic illustration of enantioseparation by CEKC applying counter
migration technique for separating basic ionized enantiomeric pair (R+ and S+) using CS in the
BGE. Filling the CS (A), injecting the enantiomeric compound (B), and conducting the run with
a vial contain BGE (C). Pink, yellow and green arrows show the apparent mobility (µapp) of the
enantiomeric pair, the CS, and the mobility of the EOF (µEOF), respectively. The CSs will have µapp
toward the anode and will migrate to the opposite direction of the detector. The blue arrows show
the difference in the speed of the migration of enantiomers upon interaction with the CS.
Successful CEKC-MS methods have been reported using different ion sources, while
ESI is the most commonly used ion type. In one study, CEKC-MS was used for simultaneous
enantioseparation and determination of a number of amphetamine-type stimulants and
ephedrine using sulfated-γ-CD as CS, which achieved LODs in order µg/mL [132]. In
another study, CEKC coupled to inductively coupled plasma-mass spectrometry (ICP-
MS) was applied for the enantioseparation and determination of oxaliplatin enantiomers
using sulfated-β-CD as CS. LOD and limit of quantification (LOQ) were 64 ng/mL and
116 ng/mL, respectively [133]. The CEKC-MS/MS method has also been reported with
further improvement in sensitivity, due to the reduction of noise, thus increase in S/N ratio,
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and the further improvement in selectivity, due to more fragmentation of ions to provide
better information about the enantiomer or its metabolite [134,135].
3.2. Identification of Individual Enantiomers
The identification of individual enantiomers is highly valuable for the quantitation
of impurity enantiomers, and to follow up a stereoselective synthesis procedure or to
determine a stereoselective metabolite [136]. The identification of individual enantiomers
of a racemate after enantiomeric separation can directly be achieved by running a reference
optically pure single enantiomer under the same electrophoretic conditions and comparing
the obtained migration time of the peak with the migration times of the two peaks of
the separated enantiomers (peak matching). Alternatively, the peak spiking approach to
the racemate sample is also a common method. When the individual enantiomers are
unavailable, several alternative approaches are used with different degrees of success
and limitations. The polarimetry or electronic circular dichroism can be used to identify
the individual enantiomers [137,138]. Enantiomers will have mirrored circular dichroism
spectra, which would be equal but opposite. Liu et al. [138] described a CE method in
combination with circular dichroism spectroscopy for the identification of enantiomeric
peaks in the absence of a single enantiomer standard. Seven enantiomeric substances
(tryptophan, tyrosine, phenylalanine, Boc-valine, Boc-leucine, ibuprofen, and naproxen)
were used in the study. The method was found to be more suitable for a nonracemic
mixture with good and stable electronic circular dichroism signals. Figure 7 shows ECD
spectra for typtophan, N-(tert-Butoxycarbonyl)-valine and ibuprofen enantiomers.
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Figure 7. ECD spectra of tryptophan (Trp), N-(tert- t l)- li e ( oc-Val), and ibuprofen (IP) with different
enantiomeric excess value (ee% value). Enantiomers of each compound have opposite signals. Reprinted with permission
from reference [138].
t ti l c i st i s c i e r i f r ation (not accurate) when the
structure of the chiral selector is available depending on the differ nt strengths of complex-
ation (discussed below). If the chiral selector is negativ ly charged nd migrates ag inst
the EOF and the e antiomer is positively charged, then the antiomer with the low in-
teraction with the complex is the one that will appear first in the electropher gram with a
shorter migration time [44]. For exampl , for CDs that migr te in the opposite direction to
the EOF, it is expected the nantiomer i v lv d in forming the more stable complex will
pr sent a long r migration time in the electrophoretic system, reaching the detector last.
However, if the chiral selector migrates in the s me direction as the EOF, it is expected the
enantiomer involved in forming the more stable co plex, presumably, presents the shortest
migration time, reaching the detector first [139]. Figure 8 schematically illustrates the chiral
discrimination process, assuming the influence of EOF and the migration direction of
the CDs.
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presents a shorter migration time.
For enantio eric i purity deter ination, e.g., fro an enantiopure phar aceutical
for ulation (supposed to contain pure enantiomeric drug), the relative concentration
sensitivity seems to be more relevant than the absolute concentration sensitivity [27].
According to ICH guidelines, the enantio eric impurity should not exceed 0.1% relative
to the main enantiomer. The determination of impurity enantiomer of 0.1% or less in
the presence of the main enantiomer in 99.9% makes the separation factor more critical
than the absolute c c tration sen itivity. It is worth noting th t the EMO plays an
important ole in this rega d, and an i purity enantiomer peak eluted before the peak f
the main enantiomer is less likely t overlap with the possible taili g effect of the main
enantio eric peak.
Sometim s rev rsal of the EMO (e.g., by using another c iral selector) might be
r commended o ensure better resol tion. Wh le also i porta t in this regard, absolute
concentration sensitivity plays a mo e crucial role in det rmination from biological samples
where the enantiomeric pair or their met bolites are present in very low concentration. It is
worth n ting that most commercially availabl si gle pure enantio eric reference materials
c tain a certain percentage of th other enantiomer as an impurity. This should be
considered when u ing the reference enantiomer for the quality control of drugs marketed
as pure enantiomers [140].
3.3. Design of Experiment
In the last decades, pharmaceutical regulatory authorities and organizations have
been demanding implementation of a risk-based approach during analytical method de-
velopment to assure the quality of experimental designs adopted to reach the optimum
analytical conditions prior to wet lab development, in addition to delimiting the Design
Space and robust areas of an analytical method before proceeding to its method valida-
tion. Notions like Analytical Quality by Design (AQbD) were introduced to represent the
analytical façade of the general Quality by Design (QbD) concept that was primarily inno-
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vated for industrial production before it extrapolates to all fields related to pharmaceutical
development. In CEKC, AQbD started replacing Quality by Testing in the last decade,
not only to find optimum values of the Critical Method Parameters (CMPs) within the
Design Space (DS) (also known as Method Operability Design Region, Knowledge Space,
Response Surface, Resolution Map, Contour Plot and Surface Plot), but also to enable a
deep understanding of the interactions taking place between analytes enantiomers and
the CSto reveal dynamics of the enantiorecognition mechanisms (supported by computer
modeling), enhance gained knowledge and risk management of the method that allows
enlightened continuous method improvement. Design of Experiments (DoE) has been
adopted as the systematic approach to assure the quality of the experimental design. In
CEKC, DoE starts by screening or scouting cmPs (numerical, such as voltage and tempera-
ture, and categorical, such as nature of chiral selector, BGE, etc.) that significantly affect
the Critical Quality Attributes (CQAs) that are predominantly enantioresolution and total
run time where the highest resolution and lowest migration time are usually the intended
Analytical Target Profile (ATP). The most common designs during this screening phase are
Fractional Factorial and Placket Burman designs, yet some reports overlook a multivariate
screening and resort to the more time-consuming One-factor-at-a-time (OFAT) (Table 2).
Settling on the most relevant cmPs is usually aided by Main Effect Plots and Pareto charts,
however none of the methods reported in the interval January 2016-March 2021 invested
effort in this phase where many used the OFAT approach, while others did not proceed
via the statistical analysis step (Table 1), probably due to the established cmPs in CEKC,
namely, voltage, temperature, nature and concentration of chiral modifier and buffer in
the BGE. In a study by Milan et al. [110], nine types of CDs were screened at four different
pH values using OFAT, meaning 36 runs, which has certainly consumed an enormous time,
while a nine-factor Placket Burman screening design would have needed only eight runs
and proper statistical interpretation using Main Effect Plots and Pareto charts.
All computation was indeed focused on the optimization phase, where designs like
full factorial, face-centered central composite designs, D-optimal designs are adopted to
produce the response surfaces and generate the multivariate or least-square regression
models related the significant cmPs to cmAs in addition to Monte Carlo simulations that are
used for accurate definition of the DS, that enables selection of the optimal working point,
robust range, or sweet spot revealed by the overlay of multiple methods operable design
region (MODR). Responses in multivariate optimization in CEKC are mostly selectivity
or resolution, and analysis time, where their simultaneous optimization is sometimes
performed via the desirability function [110,141].
Selection of the appropriate optimization method is critical to the accuracy of fit of
the regression model obtained. Long expertise of the analyst sometimes allows him to
skip this step where a selection of relevant factors to carry to the optimization design is an
expert decision; sometimes, classic trends between cmPs and CQAs like the direct relation
of run time with buffer concentration and its inverse relation with voltage can lead to
skipping those two factors in a screening study. However, there is no guarantee then of
the appropriateness of model fit that is hypothesized to be: Y = β0+ β1 × 1+ β2X2+ β3X3+
β4X4+ β11X12+ β22X22+ β33X32+ β44X42+ β12X1X2+ β13X1X3+ β14X1X4+ β23X2X3+
β24X2X4+ β34X3X4+ ε, where Y is the CQA, X are cmPs with different orders and two-way
interactions, and ε the random error.
In a study by Abdel-Megied et al. [141], a screening design was missing, and a full
factorial model of two factors at three levels was erroneously selected to optimize the
effect of CD and pH, where the linear model significantly lacked fit for all chiral selectors,
indicating either presence of quadratic of higher orders of some or all the factors that are
impossible to reveal with a linear model, or the presence of other factors that needed to be
included in the study via a systematic screening. In this study, the BGE, applied voltage,
and temperature were not screened for relevance and were set constant (50 mM phosphate-
triethanolamine, 15 kV, and 25 ◦C, respectively), and only pH and CD concentration
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were optimized. As such, the determination of a working point may be possible, yet the
definition of the MODR is impossible without a proper fit of the regression model (Table 2).
Due to the importance of CEKC in the determination of the eudismic ratio and
chiral purity of drugs, where the eutomer has a significantly higher effect of distomer
or where the latter has undesirable side effects, many studies consider DoE a backbone
of this type of studies, despite the flaws in reproducibility that seem to exist in column
preparation, thus affecting the reliability of regression models [142]. Harnisch et al. [143]
use a Central Composite Design (CCD) and Monte Carlo simulations (MCS) to define
the DS of enantioseparation of the anticonvulsant anxiolytic prepagabalin in commercial
capsules after its derivatization by dansyl chloride (Table 2).
DoE tools were also used to test method robustness prior to validation [144,145]. Using
a quick Placket Burman Design (PBD), studying the effect of small, deliberate changes
in cmPs around the optimum working point did not result in a significant change in cmAs,
namely, resolution and migration time whose ATP were resolution ≥2.5 and migration
time ≤30 min.
The calcimimetic cinacalcet was similarly the target of a similar study, where reporting
enantiopurity is requested by pharmacopeial monographs and/or regulatory agencies, yet
in contrast to prepagabalin, its R-enantiomer is the eutomer [144].
An Ishikawa fishbone diagram and Constant-Noise-Experiment (CNX) tool were used
for the screening phase in this study. Even though fractional factorial designs are more
common in electrophoretic and chromatographic DoE based studies, yet the CNX tool nicely
identified CEKC injection, detection, capillary factors, and BGE factors, such as type and
concentration of buffer, type of organic modifier, type of CD, and its degree of substitution
as Constant (C). It is, in fact, common in many DoE based CEKC studies to find phosphate
buffer in a range of 50–150 mM (less commonly citrate buffer), pH 2.5–6.5 (depending
on pKa of analyte), and temperature in a range of 15–25 ◦C and 10–15 kV (Table 1), due
to their major effect on EOF and electrophoretic mobilities. However, voltage and BGE
characteristics (buffer pH, hydroxypropyl-γ-CD concentration, and % methanol) were
considered Experimental (X) and were solely moved to the second phase of optimization.
The friendly PBD was used to test method robustness prior to validation with values
around the working point by Harnisch et al. [143] and Niedermeier et al. [146].
It is also possible to use this quick technique to validate the MODR per se, but here
at extremes of the cmP ranges and to verify that the ATP is also fulfilled in these extreme
points as reported by Pasquini et al. [144].
Even though factors affecting CEKC separations are majorly voltage, temperature,
BGE ionic strength, and pH in addition to chiral selector type and concentration, it appears
that a small % methanol [144] or isopropanol [147] may alter the enantioresolution, likely
due to its effect on BGE viscosity and conductance.
When addressing the selection of 3-D full factorial design (FFD), CEKC analysts seem
to favor face-centered CCD over CCD with axial points out of the cube space, that have a
default α-value of 1.2, even though chromatography usually use this later type of CCD.
Reports do not reason this selection of limited space face-centered CCD [143,145,146], yet
it is well known that experimental points out of the cube space are on many occasions not
practically applicable, due to instrument limitations, here probably voltage and temperature
which have recommended high and low settings, respectively. It is indeed of paramount
importance to select an applicable experimental domain to avoid breaking an experimental
design for practical or technical reasons.
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Table 2. Summary of DoE based CEKC methods: Full factorial Design, (FFD, full factorial design; fFD, fractional factorial design; CCD, Central Composite Design; BBD, Box-Behnken
Design; MCS, Monte Carlo Simulation, PBD, Placket Burman Design; Rs, resolution; t, migration time, PhB, phosphate buffer; OFAT, One-factor-at-a time).
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3.4. Molecular Modeling Applied to Enantioseparations
As mentioned in the previous sections, CE plays a crucial role in enantiomeric discrimina-
tion. In this sense, aiming to elucidate the enantioseparation process at the molecular level, as well
as the EMO, molecular modeling has proven to be an excellent auxiliary tool for the understand-
ing of molecular recognition mechanism between selector and selectand. Besides, theoretical
investigations have also been considered as powerful allies in CE experiments [148].
It is estimated that over 50% of CE enantiomeric separations occur by adding CDs
to running electrolytes. Association (i.e., selector-selectand complexes with peripheral
interactions) or inclusion complexes of the host-guest type are frequently studied. In
special, several studies have unequivocally shown that the inclusion complex formation is
not a prerequisite for chiral recognition by CDs, mainly when substituted-CDs are used,
which can offer sites of interactions with selectand. Thus, the most theoretical studies in the
enantioseparation field are devoted to CD host-guest inclusion complexes to comprehend
the complexation mechanism and to correlate the experimental results with the mode of
inclusion of the guest molecule (analyte) into the CD host (chiral selector). Furthermore,
molecular modeling has been used to explain not only selector-selectand interaction, but
also the migration phenomena observed in CE [139,149]. Previous works presented the
elucidation of chiral recognition mechanisms in separation sciences by various selectors.
Scriba reviewed the main contributions in the literature about the enantiorecognition
mechanisms of main chiral selectors, i.e., polysaccharide, cyclodextrins, macrocyclic gly-
copeptides, donor-acceptor-type selectors, chiral ion-exchangers, chiral ligand-exchangers
as well chiral micelles [150,151]. Peluso et al. [152] presented the progress in docking
and molecular dynamics (MD) simulations based on selector type. In this context, this
review section illustrates the combined approach using CE and molecular modeling for
understanding the chiral recognition mechanism using CDs.
From a structural point of view, CD complexes differ from each other in terms of
the spatial and geometric arrangement, due to the chemical nature, strength, and number
of interactions established. Under an energetic point of view, they differ in terms of
the free energy of Gibbs (∆G) formation variation, and the magnitude of the ∆G values,
fundamentally depend on the enthalpic (∆H) and entropic (−T∆S) contributions associated
with each complex formation, involving each of the enantiomers (∆G = ∆H − T∆S) [42,153].
In this sense, theoretical/computational studies can lead to a reliable prediction of EMO
through structural, topological, and energetic analyses of the CD complexes, which reveal
details on the intermolecular forces, as well as electronic and thermodynamic properties.
The computational studies combined or not with CE experiments mostly report
using classical theoretical methods, such as Molecular Dynamics (MD) and Molecular
Docking (MDoc). However, works using Semiempirical (SE) methods, hybrid techniques,
as the Quantum Mechanics/Molecular Mechanics (QM-MM), as well as pure quantum-
mechanical approach, as the Density Functional Theory (DFT) can also be found. Table 3
contains an overview of theoretical works, along with experimental data, from the years
January 2016 to March 2021 that deals with the study of chiral discrimination using CDs.
As can be seen, several research groups have dedicated themselves to study the chiral
discrimination mechanism by CDs, aiming to predict or confirm EMO.
It is important to mention that the selector–selectand interaction is only one part of the
entire separation process in CE. Another part also important is associated with the dynamics
(mobilities) involved in chiral discrimination. In this sense, MD simulations have been used
in an attempt to explain, at the molecular level, the mechanisms of chiral separation and EMO.
In 2017, Salgado et al. [154], combined NMR spectroscopy experiments with MD calcula-
tions, to obtain structural and energetic information on the interactions between clenbuterol
enantiomers with β-CD and heptakis-(2,3-di-O-acetyl)-β-CD. The binding energies be-
tween each of the enantiomers and the evaluated CDs were calculated, in addition to the
different contributions to total binding energy, divided into van der Waals, coulombic, des-
olvation, and nonpolar energy. In view of the numerical data, the authors showed that the
energies computed via MD, were proportional to the experimental equilibrium bond constants.
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Table 3. List of representative works published between 2016 and March 2021 that deal with the study of chiral discrimination by CDs for EMO prediction or confirmation in CEKC.
Analyte CDs Separation Conditions Theoretical Methodology Evidence of Interactions Ref.
Tramadol Sulfated-β-CD,carboxymethyl-β-CD
Phosphate buffer 125 mM
(pH 10), 20 kV, 30 mbar/4 s,
10 ◦C, detection at 195 nm
Semiempirical PM3/DFT
(B3LYP/6-31G+(d,p))/water solvent (PCM) Hydrogen bonds [44]
Bupropion and
hydroxybupropion sulfated-β-CD
BGE phosphate 75 mM
pH 7.0, 15 kV, 30 mbar/4 s,
15 ◦C, detection at 210 nm
Molecular dynamics simulations with




Phosphate buffer 50 mM
pH 2.0
Molecular dynamics simulations (100 ns
trajectories) using amber force field







chloride, and their mixture
Borax buffer 50 mM pH 9.0,
15 kV, 50 mbar/5 s, 25 ◦C,
detection at 226 nm
Molecular docking/molecular mechanics mM2 Hydrogen bonds [156]
Medetomidine β-CD, γ-CD, Sulfated-β-CDand highly sulfated-β-CD
Phosphate buffer 50 mM
pH 2.5, 20/−20 kV
Molecular dynamics simulations in water




Phosphate buffer 25 mM
pH 7.0, 15 kV, 50 mbar/1 s,




Details of structural analysis
were not provided [158]
Asenapine β-CD
TRIS-acetate buffer 160 mM
pH 3.5, 15 kV, 50 mbar/4 s,
20 ◦C
Semiempirical PM3/DFT PBE def2-SVP/water








acid), 25 kV, 0.5 psi/5 s, 22 ◦C,
detection at 200 and 258 nm
DFT/B3LYP(6-31G*)/water solvent (TIP3/14 Å)
(Amber 14 molecular dynamics simulations







BGE TRIS-H3PO4 50 mM
pH 2.5, 10 kV, 10 mbar/3 s,
detection at 210 nm
Molecular Mechanics Powell Method (Strength







Glycine-HCl buffer 50 mM
pH 2.0, 12 kV, 25 mbar/2 s,
35 ◦C, detection at 200 nm
Molecular docking simulations/implicit solvency
of Generalized Born
Van der Waals interactions,
hydrogen bonds, and type-π [162]
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Table 3. Cont.
Analyte CDs Separation Conditions Theoretical Methodology Evidence of Interactions Ref.
Ofloxacin Methylated-β-CD
Phosphate buffer 50 mM
pH 3.1, 20 kV, 50 mbar/5 s,
20 ◦C, detection at 276 nm
Molecular Mechanics mM2
Van der Waals interactions
and electrostatic interactions









Phosphate buffer 120 mM
pH 2.5–4.0, 20 kV, 20 psi,
20 ◦C, detection at 210 nm
Hybrid method ONIOM2: Semiempirical
PM3/DFT (B3LYP/6-31G(d,p))
Van der Waals interactions





Phosphate buffer 100 mM
pH 3.0 and ammonium
format 0.75 mM, 25 kV,
50 mbar/3 s, 15 ◦C, detection
at 230 nm.
Molecular dynamics simulations with general
amber force field with AM1-BCC load. For purpose





BGE TRIS-H3PO4 20 mM
pH 3.5, 20 kV, 50 mbar/5 s,
20 ◦C, detection at 237 nm.
Molecular mechanics (MM2) and molecular
dynamics simulations/Semiempirical method PM3
Hydrogen bond,





Phosphate buffer 60 mM
pH 2.5, 10 kV, 0.5 psi/5 s,
detection at 210 nm.
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Although most of the theoretical calculations are performed via MD simulations, some
precaution is necessary. One aspect that must be considered in MD simulations is related to
the selector-selectand interactions. It is known that multiple long- and short-range interac-
tions are involved in the chiral separations, but not all these forces are enantioselective. In
this sense, MD simulations must also be used cautiously, especially in the studies aimed to
explain EMO, which must also consider systems that have a reverse migration order, due
to concentration, pH, or other variables [55,149]. Moreover, all possible conditions must be
inserted and considered in the MD simulations, for example, selector and selectand charges,
force field, nature of the electrolytes, among others, along with experimental validation of
studied CD complexes [167,168].
On the other hand, the use of quantum mechanical high-level calculations, such as
DFT, to study the enantioseparation process has risen, especially in recent years. DFT is
fundamentally a more precise theoretical methodology than those based on molecular
mechanics, since it is more reliable and efficient in describing the energy and electronic
structure of chemical systems and complexes. In 2019, Michalska et al. [160], revealed
through DFT calculations, structural details about separating sutezolid enantiomers with
heptakis-(2,3-dimethyl-6-sulfo)-β-CD, having been demonstrated the significant influence
of the inclusion of thiomorpholine rings in the CD cavity and hydrogen bonds, in the
formation and stability of the formed diastereoisomeric complexes. Through the enthalpy
variation values (∆H) obtained, the authors demonstrated that according to the experimen-
tal conditions used, protonated sutezolid favors forming a more stable complex.
In 2017, Cecilio et al. [44] conducted a computational chiral discrimination study
of opioid tramadol with sulfated-β-CD and carboxymethyl-β-CD. Using a sequential
methodology, which involved molecular dynamics simulations, semiempirical calculations
(PM3), and DFT at the B3LYP/6-31G(d,p) level, it was possible to explain the EMO of
tramadol enantiomers through a structural and energetic association complexes analysis,
i.e., complexes formed between functional groups enantiomers with active sites outside
the CD cavity. The results showed that forming shorter and stronger hydrogen bonds
between (R)-tramadol enantiomer and CDs, led to more stable values of ∆E, which allowed
the experimental migration order prediction. Along with the theoretical results, fractions
of pure enantiomers were obtained and injected into the electrophoretic system, whose
migration times by experimental studies corroborated with theoretical predictions.
In 2019, Pires et al. [155] developed an enantioselective method for simultaneous
separation of bupropion and hydroxyibrupropion using sulfated-β-CD as a chiral selec-
tor. After optimizing the experimental conditions that influence the separation, such
as concentration and pH of BGE and concentration and type of CD, it was possible to
obtain an electropherogram with optimized conditions. The EMO was elucidated us-
ing DFT calculations at B97D/6-31G(d,p) level. One interaction of hydrogen bond at a
distance of 2 Å was enough to (S)-bupropion@sulfated-β-CD complex to show greater
stability than (R)-bupropion@sulfated-β-CD. Similar behavior was also observed for the
hydroxybupropion@sulfated-β-CD complexes. Notably, the theoretical study contribution
to the experiment proved to be very relevant, since it was possible to determine the EMO.
Currently, our research group is involving the enantioselective separation of the
amlodipine using carboxymethyl-β-CD as a chiral selector. Figure 9 shows an electrophero-
gram with optimized conditions, which are similar to those proposed by Hancu et al. [169].
In this condition, (R)-amlodipine enantiomer presented a migration time shorter than
the (S)-amlodipine enantiomer. Combining the experiments with PM3/DFT calculations
(B97D/6-31G(d,p)), it was possible to explain at a molecular level the diastereoisomeric
complex (S)-amlodipine@carboxymethyl-β-CD (∆G = −15.8 kcal/mol) formation, more
stable than (R)-amlodipine@carboxymethyl-β-CD (∆G = −12.7 kcal/mol), due to the for-
mation of stronger hydrogen bonds by including the (S)-amlodipine enantiomer on the
primary face of the CD.
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Figure 9. Electropherogram related to conditions optimized for enantioseparation of amlodipine and diastereoisomeric 
complexes obtained via DFT calculations (B97D/6-31G(d,p)) in the aqueous phase. Experimental conditions: 5.5 mg/mL 
carboxymethyl-β-CD in 50 mM BGE phosphate (NaH2PO4) pH 4.0; uncoated fused-silica capillary 75 µm id × 62.5 cm (71 
cm to the detector); hydrodynamic injection using 40 mbar × 4 s; separation voltage at 15 kV; UV detection at 195 nm. 
Source: Elaborated by the authors themselves (our unpublished results). 
Despite the rapid increase in the number of papers involving DFT calculations in 
the last years, semiempirical methods still attract a great deal of attention owing to their 
lower computational demands. For example, semiempirical methods, such as PM3 and 
PM6, have been found to give good estimates of molecular properties than ab initio and 
DFT methods at even lower computational cost, making it an attractive method for the 
description of inclusion complexes [170]. Budău et al. [158] studied, via semiempirical cal-
culations RM1, the formation of the host-guest complexes formed between citalopram and 
carboxymethyl-β-CD. The authors correlated EMO, with the formation of a more stable 
complex involving the enantiomer with longer migration time, i.e., (R)-citalopram@car-
boxymethyl-β-CD (ΔE = −67.75 kJ/mol), than the antipode (S)-citalopram@carboxymethyl-
β-CD (ΔE = −48.32 kJ/mol). 
Several papers published in the last six years, presented in this review, show great 
potential of molecular modeling for understanding enantioselective recognition mecha-
nisms. A systematic theoretical analysis, when used in combination or not with CE exper-
iments, can provide a good perspective on the enantioseparation process, serving as a 
valuable auxiliary method for studying chiral recognition mechanisms. Finally, efforts in 
the computational chemistry field are continuously required—since the mechanistic as-
pects of selector-selectand interactions, at the molecular level, are still, in many cases, not 
fully understood. 
Author Contributions: Conceptualization, S.E.D.; methodology, S.E.D.; R.S.H.; K.B.B.; resources, 
S.E.D.; C.S.N.J.; R.S.H.; K.B.B.; data curation, S.E.D.; C.F.S.; C.S.N.J.; R.S.H.; K.B.B.; writing—original 
draft preparation, S.E.D.; C.F.S.; C.S.N.J.; R.S.H.; K.B.B.; writing—review and editing, S.E.D.; R.S.H.; 
K.B.B.; visualization, S.E.D.; C.F.S.; C.S.N.J.; R.S.H.; K.B.B.; project administration, S.E.D. All authors 
have read and agreed to the published version of the manuscript. 
Funding: This research received no external funding. 
Institutional Review Board Statement: Not applicable. 
Figure 9. Electropherogram related to conditions optimized for enantioseparation of amlodipine and diastereoisomeric
complexes obtained via DFT calculations (B97D/6-31G(d,p)) in the aqueous phase. Experimental conditions: 5.5 mg/mL
carboxymethyl-β-CD in 50 mM BGE phosphate (NaH2PO4) pH 4.0; uncoated fused-silica capillary 75 µm id × 62.5 cm
(71 cm to the detector); hydrodynamic injection using 40 mbar × 4 s; separation voltage at 15 kV; UV detection at 195 nm.
Source: Elaborated by the authors themselves (our unpublished results).
Despite the rapid increase in the number of papers involving DFT calculations
in the last years, semiempirical methods still attract a great deal of attention owing
to their lower computational demands. For example, semiempirical methods, such as
PM3 and PM6, have been found to give good estimates of molecular properties than
ab initio and DFT methods at even lower computational cost, making it an attractive
method for the description of inclusion complexes [170]. Budău et al. [158] studied, via
semiempirical calculations RM1, the formation of the host-guest complexes formed be-
tween citalopram and c rboxymethyl-β-CD. The authors c related EMO, with the for-
mation of a more stable complex inv lving the enantiomer with longer migr tion time,
i.e., (R)-c tal pram@carboxymethyl-β-CD (∆E = −67.75 kJ/mol), than the antipode (S)-
citalopram@carboxymethyl-β-CD (∆E = −48.32 kJ/mol).
Several papers published in the last six years, presented in this review, show great
potential of molecular modeling for understanding enantioselective recognition mech-
anisms. A systematic theoretical analysis, when used in combination or not with CE
experiments, can provide a good perspective on the enantioseparation process, serving as
a valuable auxiliary method for studying chiral recognition mechanisms. Finally, efforts
in the computational chemistry field are continuously required—since the mechanistic
aspects of selector-selectand interactions, at the molecular level, are still, in many cases, not
fully understood.
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